Human and rat cyclooxygenases are pharmacologically distinct

Advances in Experimental Medicine and Biology

Volumn 407, Issue , 1996, Pages 67-71

  Ramesha, Chakk S ^a  

^a Roche Biosciences ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIROLAC; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DICLOFENAC; IBUPROFEN; INDOMETACIN; KETOPROFEN; NONSTEROID ANTIINFLAMMATORY AGENT; SUPROFEN; ZOMEPIRAC;

AMINO ACID SEQUENCE; CONFERENCE PAPER; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; NONHUMAN; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; SCREENING; SEQUENCE HOMOLOGY;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; HUMANS; ISOENZYMES; MEMBRANE PROTEINS; MOLECULAR STRUCTURE; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RATS; RECOMBINANT FUSION PROTEINS; SPECIES SPECIFICITY; SUBSTRATE SPECIFICITY; SULFONAMIDES;

EID: 0030410451     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Conference Paper

References (14)

1. J-Y. Fu, J.L Masferrer, K. Seibert, A. Raz, and P. Needleman, The induction and suppression of prostaglandin H2 synthase (cyclooxygenase) in human monocytes. J. Biol. Chem. 265: 16737 (1990).
2. D.A. Kujubu, B.S. Fletcher, B.C. Varnum, R.W. Lim, and H. R. Herschman, TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. J. Biol. Chem. 266: 12866 (1991).
3. W.L. Smith, Prostanoid biosynthesis and mechanism of action. Am. J. Physiol. 263: F181 (1992).
4. J. Sirois, and J. Richards, Purification and characterization of a novel, distinct isoform of prostaglandin endoperoxide synthase induced by human chorianic gonadotropin in granulosa cells of rat preovulatory follicles. J. Biol. Chem. 267: 6382 (1992)
5. E.A. Mead, W.L. Smith, and D.L. DeWitt, Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non- steroidal anti-inflammatory drugs. J. Biol. Chem. 268: 6610 (1993).
6. J. Barnett, J. Chow, D. Ives, M. Chiou, R Mackenzie, E. Osen, B Nguyen, S. Tsing, C. Bach, J. Freire, H Chan, E. Sigal, and C. Ramesha, Purification, characterization and selective inhibition of human prostaglandin G/H synthase 1 and 2 expressed in the baculovirus system. Biochim. Biophys. Acta 1209: 130 (1994).
7. J.R Vane, and R.M. Botting, A better understanding of anti-inflammatory drugs based on isoforms of cyclooxygenase (COX-1 and COX-2). Adv. Prost. Thrombx. and Lekotriene Res. 23: 41 (1995).
8. R.J. Kulmacz, and W.E.M. Lands, (1987) In prostaglandins and related substances: practical approach (Dinedetto, C.C. et. al eds) pp209-225, IRL Press, Washington, DC.
9. J. Masferrer, B.S. Sweifel, P.T. Manning, S.D. Hauser, K.M. Leahy, W.G. Smith, P.C. Isakson, and K. Seibert, Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic. Proc. Natl. Acad. Sci. USA. 91: 3228 (1994).
10. T. Klein, R.M. Nusing, J. Pfeislchifter, and V. Ullrich, Selective inhibition of cyclooxygenase 2. Biochem. Pharmacol. 48: 1605 (1994).
11. K. Seibert, Y. Zhang, K. Leahy, S. Hauser, J. Masferrer, W. Perkins, L. Lee, and P. Isakson, Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain. Proc. Natl. Acad. Sci. USA. 91: 12013 (1994).
12. D.B. Reitz, J.J. Li, M.B. Norton, E.J. Reinhard, J.T. Collins, G.D. Anderson, S.A. Gregory, C.M. Koboldt. W.E. Perkins, K. Seibert, and P.C. Isakson, Selective cyclooxygenase inhibitors: novel 1,2-diarylcyclopentenes are potent and orally active COX-2 inhibitors. J.Med.Chem. 37: 3878 (1994).
13. A. Ward, and R.N. Brogden, Nimesulide. A preliminary review of its pharmacological properties and therapeutic efficacy in inflammation and pain states. Drugs 36: 732 (1988).
14. R. Davis, and R.N. Brogden, Nimesulide. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy. Drugs 48: 431 (1994).